In vitro radiosensitization of human cervical carcinoma cells by combined use of 13-cis-retinoic acid and interferon-α2a

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 4, 1998, Pages 869-873

  Ryu, Samuel ^a   Kim, Ok Bae ^b   Kim, Sang Hie ^b   He, Shao Quin ^c   Kim, Jae Ho ^b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

13 cis Retinoic acid; Interferon 2a; Radiosensitization; Retinoic acid receptor

Indexed keywords

ALPHA2A INTERFERON; ISOTRETINOIN; RADIOSENSITIZING AGENT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOMA CELL; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIZATION; TREATMENT INDICATION; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; CELL DIVISION; FEMALE; HELA CELLS; HUMANS; INTERFERON ALFA-2A; ISOTRETINOIN; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0031803517     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00111-4     Document Type: Article

References (32)

1. Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem. Biophys. Acta. 605:1981;33-91.
2. Hong W.K., Endicott J., Itri L.M., Doos W., Batsakis J.G., Bell R., Foffnof S., Byers R., Atkinson E.N., Vaughan C., Toth B.B., Kramer A., Dimery I.W., Skipper P., Strong S. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med. 315:1986;1501-1505.
3. Hong W.K., Lippman S.M., Itri L.M., Karp D.D., Lee J.S., Byers R.M., Schnatz S.P., Kramer A.M., Lotan R., Dimery I.W., Brown B.W., Goepfert H. Prevention of second tumors with isotretinoin in squamous cell carcinoma of the head and neck. N. Engl. J. Med. 323:1990;795-801.
4. Lippman S.M., Parkinson D.R., Itri L.M., Weberr R.S., Schantz S.P., Ota D.M., Schusterman M.A., Krakoff I.H., Gutterman J.U., Hong W.K. 13-cis-Retinoic acid and interferon α-2a Effective combination therapy for advanced squamous cell carcinoma of the skin . J. Natl. Cancer Inst. 84:1992;235-241.
5. Lippman S.M., Kavanagh J.J., Paredes-Espinoza M., Delgadillo-Mardrueno F., Paredes-Casillas P., Hong W.K., Holdener E., Krakoff I.H. 13-cis-retinoic acid plus interferon α-2a Highly active systemic therapy for squamous cell carcinoma of the cervix . J. Natl. Cancer Inst. 84:1992;241-245.
6. Kirkwood J.M., Ernstaff M.S. Interferons in the treatment of human cancers. J. Clin. Oncol. 2:1984;336-352.
7. Holsti L.R., Mattson K., Niiranen A. Enhancement of radiation effects by alpha interferon in the treatment of small cell carcinoma of the lung. Int. J. Radiat. Oncol. Biol. Phys. 13:1987;1161-1166.
8. Dritschilo A., Mossman K., Gray M. Potentiation of radiation injury by interferon. Am. J. Clin. Oncol. 5:1982;79-82.
9. Torrissi J., Berg C., Bonnem E., Dritschilo A. The combined use of interferon and radiotherapy in cancer management. Semin. Oncol. 13:1986;78-83.
10. Marth C., Daxenbichler G., Dapunt O. Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultures breast cancer cells. J. Natl. Cancer. Inst. 77:1986;1197-1202.
11. Peck R., Bollag W. Potentiation of retinoid induced differentiation of HL-60 and U937 cell lines by cytokines. Eur. J. Cancer. 27:1991;53-57.
12. Frey J.R., Peck R., Bollag W. Antiproliferative activity of retinoids, interferon-α and their combination in five human transformed cell lines. Cancer Lett. 57:1991;223-227.
13. Ryu S., Gabel M., Khil M.S., Lee Y.J., Kim S.H., Kim J.H. Estramustine A novel radiation enhancer in human carcinoma cells . Int. J. Radiat. Oncol. Biol. Phys. 30:1994;99-104.
14. Albright N. Computer program for the analysis of cellular survival data. Radiat. Res. 112:1987;331-340.
15. Clemens M.D., McNurlan M.A. Regulation of cell proliferation and differentiation by interferons. Biochem. J. 226:1985;345-360.
16. Bollag W., Peck R., Frey J.R. Inhibition of proliferation by retinoids and cytokines and their combination in four human transformed epithelial cell lines. Cancer Lett. 62:1992;167-172.
17. Lotan R., Dawson M.I., Zou C.C., Kong L., Lotan D., Zou C.P. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and α-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res. 55:1995;232-236.
18. DeLaney T.F., Afridi N., Taghian A.G., Sanders D.A., Fruleihan N.S., Faller D.V., Nogueira C.P. 13-cis-Retinoic acid with α-2a-interferon enhances radiation cytotoxicity in head and neck squamous cell carcinoma in vitro. Cancer Res. 56:1996;2277-2280.
19. Duchesne G.M., Hutchinson L.K. Reversible changes in radiation response induced by all-trans retinoic acid. Int. J. Radiat. Oncol. Biol. Phys. 33:1996;875-880.
20. Antonadoi D., Cardamakis E., Iliopoulos P., Sarris G., Malamos N., Kotoulas I.G., Throuvalas N. Comparative study between exclusive irradiation or combined with IFN-α2a and isotretinoin in Stage IIB and III cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 36:(Suppl.):1996;219.
21. De Luca L.M. Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J. 5:1991;2924-2933.
22. Hoffman B., Lejmann J.M., Zhang X.K., Hermann T., Husmann M., Graupner G., Pfahl M. A retinoic acid receptor-specific element controls the retinoic acid receptor-β promotor. Mol. Endocrinol. 4:1990;1727-1736.
23. DeThe H., del Mar Vivanco-Ruiz M., Tiollais P., Stunnenberg H., Dejean A. Identification of retinoic acid response element in the retinoic acid receptor-β gene. Nature (Lond.). 343:1990;177-178.
24. Bartsch D., Boye B., Baust C., zur Hausen H., Schwarz E. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of retinoic acid receptor β gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J. 11:1992;2283-2291.
25. Hoffman A.D., Engelstein D., Bogenrieder T., Papandreou C.N., Steckelman E., Dave A., Motzer R.J., Dmitrovsky E., Albino A.P., Nanus D.M. Expression of retinoic acid receptor β in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid. Clin. Cancer Res. 2:1996;1077-1082.
26. Li X.S., Shao Z.M., Sheikh S., Eiseman J.L., Sentz D., Jetten A.M., Chen J.C., Dawson M.I., Aisner S., Rishi A.K., Gutierrez P., Schnapper L., Fontana J.A. Retinoic acid nuclear receptor β inhibits breast carcinoma anchorage independent growth. J. Cell Physiol. 165:1995;449-458.
27. Seewaldt V.L., Johnson B.S., Parker M.B., Collins S.J., Swisshelm K. Expression of retinoic acid receptor β mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ. 6:1995;1077-1088.
28. Chang A.Y.C., Keng P.C. Potentiation of radiation cytotoxicity by recombinant interferon, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle. Cancer Res. 47:1987;4338-4341.
29. Lancilloti F., Giandomenico V., Affabris E., Fiorucci G., Romeo G., Rossi G.B. Interferon-α2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells. Cancer Res. 55:1995;3158-3164.
30. Giandomenico V., Lancillotti F., Fiorucci G., Percario Z.A., Rivabene R., Malorni W., Affabris E., Romeo G. Retinoic acid and IFN inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines Role of IRF-1 and TGase II-dependent pathway . Cell Growth Differ. 8:1997;91-100.
31. Tamura T., Ishihara M., Lamphier M.S., Tanaka N., Oishi I., Aizawa S., Matsuyama T., Mak T.W., Taki S., Taniguchi T. An IRF-1 dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature (Lond.). 376:1995;596-599.
32. Zhang L.X., Mills K.J., Dawson M.I., Collins S.J., Jetten A.M. Evidence for the involvement of retinoic acid receptor RAR alpha-dependent signaling pathway in the induction of tissue glutaminase and apoptosis by retinoids. J. Biol. Chem. 270:1995;6022-6029.